BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18755587)

  • 1. Discovery of thieno[2,3-c]pyridines as potent COT inhibitors.
    George D; Friedman M; Allen H; Argiriadi M; Barberis C; Bischoff A; Clabbers A; Cusack K; Dixon R; Fix-Stenzel S; Gordon T; Janssen B; Jia Y; Moskey M; Quinn C; Salmeron JA; Wishart N; Woller K; Yu Z
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4952-5. PubMed ID: 18755587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
    Wang Y; Duraiswami C; Madauss KP; Tran TB; Williams SP; Deng SJ; Graybill TL; Hammond M; Jones DG; Grygielko ET; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4916-9. PubMed ID: 19664922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.
    Hanan EJ; Fucini RV; Romanowski MJ; Elling RA; Lew W; Purkey HE; VanderPorten EC; Yang W
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5186-9. PubMed ID: 18790636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-alpha production.
    Cusack K; Allen H; Bischoff A; Clabbers A; Dixon R; Fix-Stenzel S; Friedman M; Gaumont Y; George D; Gordon T; Grongsaard P; Janssen B; Jia Y; Moskey M; Quinn C; Salmeron A; Thomas C; Wallace G; Wishart N; Yu Z
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1722-5. PubMed ID: 19217782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of indazoles as inhibitors of Tpl2 kinase.
    Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors.
    Seefeld MA; Rouse MB; McNulty KC; Sun L; Wang J; Yamashita DS; Luengo JI; Zhang S; Minthorn EA; Concha NO; Heerding DA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2244-8. PubMed ID: 19285393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.
    Fucini RV; Hanan EJ; Romanowski MJ; Elling RA; Lew W; Barr KJ; Zhu J; Yoburn JC; Liu Y; Fahr BT; Fan J; Lu Y; Pham P; Choong IC; VanderPorten EC; Bui M; Purkey HE; Evanchik MJ; Yang W
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5648-52. PubMed ID: 18793847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.
    Miyazaki Y; Nakano M; Sato H; Truesdale AT; Stuart JD; Nartey EN; Hightower KE; Kane-Carson L
    Bioorg Med Chem Lett; 2007 Jan; 17(1):250-4. PubMed ID: 17027260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.
    Tong Y; Stewart KD; Thomas S; Przytulinska M; Johnson EF; Klinghofer V; Leverson J; McCall O; Soni NB; Luo Y; Lin NH; Sowin TJ; Giranda VL; Penning TD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5206-8. PubMed ID: 18790640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCtheta.
    Nathan Tumey L; Boschelli DH; Lee J; Chaudhary D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4420-3. PubMed ID: 18606543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors.
    Moretto AF; Kirincich SJ; Xu WX; Smith MJ; Wan ZK; Wilson DP; Follows BC; Binnun E; Joseph-McCarthy D; Foreman K; Erbe DV; Zhang YL; Tam SK; Tam SY; Lee J
    Bioorg Med Chem; 2006 Apr; 14(7):2162-77. PubMed ID: 16303309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
    Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors.
    Ni Y; Gopalsamy A; Cole D; Hu Y; Denny R; Ipek M; Liu J; Lee J; Hall JP; Luong M; Telliez JB; Lin LL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5952-6. PubMed ID: 21862328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
    Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.
    Hung JM; Arabshahi HJ; Leung E; Reynisson J; Barker D
    Eur J Med Chem; 2014 Oct; 86():420-37. PubMed ID: 25194934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.
    Hornberger KR; Berger DM; Crew AP; Dong H; Kleinberg A; Li AH; Medeiros MR; Mulvihill MJ; Siu K; Tarrant J; Wang J; Weng F; Wilde VL; Albertella M; Bittner M; Cooke A; Gray MJ; Maresca P; May E; Meyn P; Peick W; Romashko D; Tanowitz M; Tokar B
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4517-22. PubMed ID: 23850198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.
    Lin X; Murray JM; Rico AC; Wang MX; Chu DT; Zhou Y; Del Rosario M; Kaufman S; Ma S; Fang E; Crawford K; Jefferson AB
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4163-8. PubMed ID: 16765046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of thieno[2,3-b]pyridine derivatives as novel c-Src inhibitors.
    Pevet I; Brulé C; Tizot A; Gohier A; Cruzalegui F; Boutin JA; Goldstein S
    Bioorg Med Chem; 2011 Apr; 19(8):2517-28. PubMed ID: 21459579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; PittalĂ  V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Wang H; Ruan Z; Li JJ; Simpkins LM; Smirk RA; Wu SC; Hutchins RD; Nirschl DS; Van Kirk K; Cooper CB; Sutton JC; Ma Z; Golla R; Seethala R; Salyan ME; Nayeem A; Krystek SR; Sheriff S; Camac DM; Morin PE; Carpenter B; Robl JA; Zahler R; Gordon DA; Hamann LG
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3168-72. PubMed ID: 18485702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.